Assessing the impact of vomiting episodes on outcome after acetaminophen poisoning

Sa'ed H Zyoud1, Rahmat Awang, Syed Azhar Syed Sulaiman

  • 1WHO Collaborating Centre for Drug Information, National Poison Centre, Universiti Sains Malaysia (USM), Penang, Malaysia. saedzyoud@yahoo.com

Insights

Vomiting is common in acetaminophen poisoning and may indicate a higher risk of kidney and liver damage. Increased vomiting episodes at presentation signal potential organ toxicity.

Area of Science:

  • Toxicology
  • Clinical Medicine
  • Prognostic Markers

Background:

  • Acetaminophen (paracetamol) overdose is a frequent cause of acute liver injury.
  • Identifying early indicators of poor prognosis is crucial for effective clinical management and targeted interventions.

Purpose of the Study:

  • To determine the prevalence, characteristics, and predictors of vomiting in acetaminophen poisoning.
  • To investigate the association between vomiting episodes upon initial presentation and patient outcomes.

Main Methods:

  • Retrospective cohort study of 291 patients admitted within 24 hours of acetaminophen ingestion.
  • Data collected over a 5-year period (2004-2008).
  • Statistical analysis included parametric and non-parametric tests; logistic regression identified risk factors.

Main Results:

  • Vomiting occurred in 65.3% of patients at initial presentation.
  • Risk factors for vomiting included acetaminophen dose ≥10 g and latency >8 hours.
  • Increased vomiting episodes correlated with elevated prothrombin time, bilirubin, creatinine, potassium, longer hospital stay, and higher serum acetaminophen levels.

Conclusions:

  • Vomiting is a prevalent symptom in acetaminophen poisoning.
  • An increased number of vomiting episodes at first presentation serves as a significant risk marker for subsequent nephrotoxicity and hepatotoxicity.

Related Concept Videos

Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...